COMPOUNDING FINDER
Tirzepatide is a dual GIP/GLP-1 receptor agonist prescribed for type 2 diabetes and chronic weight management. Arizona patients with a documented clinical need — such as an allergy to inactive ingredients in Mounjaro or Zepbound, or a requirement for a non-standard dose — may be eligible for a compounded version from a licensed pharmacy.
Arizona’s population is concentrated in the Phoenix and Tucson metro areas, but patients in rural communities across the state may have limited access to specialty compounding. Compounding Finder helps Arizona residents compare licensed pharmacies that ship statewide.
Compounded tirzepatide is prepared by licensed compounding pharmacies using the same active pharmaceutical ingredient found in FDA-approved Mounjaro and Zepbound. Compounded versions can be customized with dose flexibility, alternative forms, and excipient adjustments for patients with documented clinical needs.
Yes. Compounded tirzepatide is available to Arizona patients through licensed compounding pharmacies. The Arizona State Board of Pharmacy oversees in-state compounding activities.
Key requirements:
Compounded tirzepatide in Arizona typically costs between $150 and $450 per month, depending on dosage, form, and pharmacy.
.png){kind=spacer}
